weight-loss drugs
Scope
Date
~
-
Bio & Pharma
Icure wins $2.85 mn lidocaine cataplasm order from Guatemala
South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...
Dec 19, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
ISU Abxis gets patent for Alzheimer drug candidate in Taiwan
South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Executive reshuffles
Lotte Group’s 3rd-generation son comes to the fore
Shin Yoo-yeol, the eldest son of Lotte Group Chairman Shin Dong-Bin, was promoted to lead the group’s new division to be launched within its h...
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Sovereign wealth funds
KIC recoups 40% of 2022’s loss on stock, bond gains
Korea Investment Corp. (KIC) posted a 7.12% return on total asset investments in the first eight months of this year, recouping about 40% of last ye...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Merck team up for AI tech for new drug
South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an arti...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Theraject Asia applies for microneedle patent in US
South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a const...
Oct 27, 2023 (Gmt+09:00)
-
Earnings
SK Hynix logs Q3 losses; to ship LPDDR5T to Qualcomm
SK Hynix Inc., the world’s No. 2 memory chipmaker, on Thursday reported its fourth straight quarterly loss, but narrowed the shortfall thanks ...
Oct 26, 2023 (Gmt+09:00)
-
Earnings
LG Display narrows Q3 losses, sees turnaround in Q4
LG Display Co. said on Wednesday it will likely turn a profit in the fourth quarter of this year, snapping its losing streak of the past six quarter...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to enter China’s botulinum toxin market with Newlux
South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cut...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Zuellig mulls acquiring S.Korea’s top drug distributor Geo-Young
Asia’s leading drug distributor Zuellig Pharma is considering the acquisition of Geo-Young Corp., the largest medicine wholesaler in South Kor...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Red ginseng proven to treat drug addiction: Research
It has been revealed that red ginseng significantly improves drug addiction and withdrawal symptoms caused by substance abuse. The research results ...
Oct 17, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
Oct 17, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy develops container loss prevention device
South Korean shipbuilder Samsung Heavy Industries on Tuesday revealed its latest invention Special Structure Anti-Container Loss (SSA-CL), using its...
Oct 17, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax forms dedicated suncare OTC team
Cosmax Inc., South Korea's largest cosmetics manufacturer that specializes in original design manufacturing (ODM), announced on Thursday the establi...
Oct 12, 2023 (Gmt+09:00)
-
Earnings
Samsung Electronics’ narrowed Q3 chip losses fuel more bullish outlook
Samsung Electronics Co., the world’s largest maker of memory chips, smartphones and TVs, said on Wednesday it likely posted a 78% drop in it...
Oct 11, 2023 (Gmt+09:00)